The Pharmaceutical Journal
Vol 279 No 7461 p69
21 July 2007

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Products

Accessing SPCs
The summaries of product characteristics and patient information leaflets for medicines licensed in the UK are available online

Prescription Products
• Teva perindopril
• Utrogestan
SPC changes
• Forsteo
• Humatrope
Products miscellany
• BeneFIX
• Lucentis

Alert Sensodyne Original and Sensodyne Mint

Prescription Products

Teva perindopril
Perindopril tablets are now available from Teva UK.
Net price:
30 x 2mg, £9.30
30 x 4mg, £9.30
30 x 8mg, £9.30
Legal category: POM.

Utrogestan
Utrogestan capsules are now available from Ferring Pharmaceuticals, indicated for adjunctive use with oestrogen in post-menopausal women with an intact uterus.
Net price:
30 x 100mg, £5.70
15 x 200mg, £5.70
Legal category: POM.

Back to Top

SPC changes

Forsteo
Forsteo (teriparatide; Lilly) is now indicated for treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. Information to support the change in indication has been added to Forsteo’s summary of product characteristics.

Humatrope
Humatrope (somatropin; Lilly) has a new indication for growth disturbance in short children born small for gestational age who fail to show catch-up growth by four years of age or later. The administration and special warnings sections of the summary of product characteristics have been updated accordingly.

Back to Top

Products miscellany

BeneFIX
Wyeth has assumed responsibility for the marketing and distribution of BeneFIX (nonacog alfa recombinant coagulation factor IX) from Baxter Healthcare.
Customer services on 0845 850 5544.
Medical information on 0845 367 0098.

Lucentis
The shelf like of Lucentis (ranibizumab; Novartis) has been extended from 18 to 24 months.

Back to Top